Smolen JS - Search Results

1

Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis.

Radner H, Smolen JS, Aletaha D. Radner H, et al. Among authors: smolen js. Rheumatology (Oxford). 2011 Feb;50(2):381-8. doi: 10.1093/rheumatology/keq334. Epub 2010 Oct 29. Rheumatology (Oxford). 2011. PMID: 21036875

2

Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis.

Graninger WB, Hassfeld W, Pesau BB, Machold KP, Zielinski CC, Smolen JS. Graninger WB, et al. Among authors: smolen js. J Rheumatol. 1991 Oct;18(10):1621-2. J Rheumatol. 1991. PMID: 1765991

3

Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.

Steiner G, Studnicka-Benke A, Witzmann G, Höfler E, Smolen J. Steiner G, et al. J Rheumatol. 1995 Mar;22(3):406-12. J Rheumatol. 1995. PMID: 7783054

4

Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis.

Hassfeld W, Steiner G, Graninger W, Witzmann G, Schweitzer H, Smolen JS. Hassfeld W, et al. Among authors: smolen js. Br J Rheumatol. 1993 Mar;32(3):199-203. doi: 10.1093/rheumatology/32.3.199. Br J Rheumatol. 1993. PMID: 8448608

5

Early arthritis therapy: rationale and current approach.

Machold KP, Eberl G, Leeb BF, Nell V, Windisch B, Smolen JS. Machold KP, et al. Among authors: smolen js. J Rheumatol Suppl. 1998 Jul;53:13-9. J Rheumatol Suppl. 1998. PMID: 9666413 Review.

6

Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains.

Smolen JS, Strand V, Cardiel M, Edworthy S, Furst D, Gladman D, Gordon C, Isenberg DA, Klippel JH, Petri M, Simon L, Tugwell P, Wolfe F. Smolen JS, et al. J Rheumatol. 1999 Feb;26(2):504-7. J Rheumatol. 1999. PMID: 9972996

7

Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients.

Wiesinger GF, Quittan M, Graninger M, Seeber A, Ebenbichler G, Sturm B, Kerschan K, Smolen J, Graninger W. Wiesinger GF, et al. Br J Rheumatol. 1998 Dec;37(12):1338-42. doi: 10.1093/rheumatology/37.12.1338. Br J Rheumatol. 1998. PMID: 9973161 Clinical Trial.

8

Cytokine production by synovial T cells in rheumatoid arthritis.

Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A, Kunaver M, Zenz P, Smolen JS. Steiner G, et al. Among authors: smolen js. Rheumatology (Oxford). 1999 Mar;38(3):202-13. doi: 10.1093/rheumatology/38.3.202. Rheumatology (Oxford). 1999. PMID: 10325658

9

Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritis.

Hueber W, Hassfeld W, Smolen JS, Steiner G. Hueber W, et al. Among authors: smolen js. Rheumatology (Oxford). 1999 Feb;38(2):155-9. doi: 10.1093/rheumatology/38.2.155. Rheumatology (Oxford). 1999. PMID: 10342629

10

Development of a disease activity index for the assessment of reactive arthritis (DAREA).

Eberl G, Studnicka-Benke A, Hitzelhammer H, Gschnait F, Smolen JS. Eberl G, et al. Among authors: smolen js. Rheumatology (Oxford). 2000 Feb;39(2):148-55. doi: 10.1093/rheumatology/39.2.148. Rheumatology (Oxford). 2000. PMID: 10725064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

830 results

Search Page

Filters